Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »


  • Eudendron
  • Via Ribes, 5
  • Collerotto Giacosa (TO) , 10010

Eudendron is a start-up company devoted to the discovery and development of a new generation of Kinase inhibitors in the area of oncology personalized medicine. The company's molecular design aims to develop safer and effective drugs able to overcome drug resistance. Eudendron’s new generation of Kinase inhibitors will be the result of a drug process called KemKinase, which encloses molecular designs and in silico validation technology coupled to a Kinome-wide strategy, revealing at a very early stage the full spectrum of Kinase targets associated to the newly identified chemical classes.

Related To This Company